-
Diagnostics World News | A pair of molecular diagnostics leaders and biotech innovators are building on their track record of fitting science to an unmet clinical need tied to the patient journey with a vaginal swab for detecting—or sometimes more importantly, ruling out—endometrial cancer in women with abnormal postmenopausal bleeding.
Jun 10, 2026
-
Diagnostics World News | Illumina plans a new portfolio of whole genome sequencing oncology research offerings, starting with a kit for molecular residual disease (MRD) research that the company hopes will enable more labs to adopt MRD detection for clinical research. The MRD research solution is available today for early access to select partners and will launch for global customers next year.
Jun 8, 2026
-
Diagnostics World News | A prominent urologic oncologist has helped develop a urine test found to be strikingly predictive of bladder cancer recurrence among patients undergoing surgery followed by BCG therapy, the current gold standard treatment regimen. The liquid biopsy also tends to identify recurrence risk that is missed by routine cystoscopy exams.
Jun 4, 2026
-
Diagnostics World News | At last month's Bio-IT World Conference & Expo, the opening plenary session featured an intimate series of paired conversations, each designed to place a different set of puzzle pieces on the table, examining that puzzle from four distinct vantage points — patient experience, AI-assisted diagnostics, venture investment, and policy reform — with each conversation delivering a bit more clarity to the emerging picture.
Jun 2, 2026